BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• BioCapital

  Immunomic Scientist Dr. Pratima Sinha to Speak at the International Conference on Vaccine Research and Development

  Immunomic present at the 3rd Annual International Conference on Vaccine Research and Development. Dr. Sinha will discuss her research employing LAMP technology in hopes of enhancing antitumor immunity.

  November 13, 2017

   · 

  2 min read
• Drug Development

  Neural Analytics Announces Data That Demonstrates Its Portable Transcranial Doppler Technology Can Accurately Measure Early Strokes

  Neural Analytics announced the results from the first phase of the EXPEDITE.

  November 13, 2017

   · 

  7 min read
• Policy

  European Medicines Agency Grants Alnylam Accelerated Assessment of Patisiran for Patients with Hereditary ATTR (hATTR) Amyloidosis

  Alnylam intends to file a marketing authorization application (MAA) in the European Union (EU) at year-end 2017.

  November 13, 2017

   · 

  9 min read
• Bio NC

  vTv to Host Key Opinion Leader Event to Discuss the Current State of Clinical Development in Alzheimer’s Disease

  vTv announced that the Company will host a key opinion leader (KOL) presentation and webcast focused on the current state of clinical development in Alzheimer’s disease in New York City on Thursday, November 16, 2017 from 8:00 am to 10:00 am ET.

  November 13, 2017

   · 

  5 min read
• Policy

  CEL-SCI Announces Update on Arbitration Against Former Clinical Research Organization

  The last witness in the arbitration hearing testified on Wednesday, November 8, 2017, and no further witnesses or testimony are expected.

  November 13, 2017

   · 

  3 min read
• Genetown

  Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2017

  Enanta management will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on Enanta’s business, including its research and development pipeline.

  November 13, 2017

   · 

  2 min read
• Bio NC

  LabCorp Earns 100 Percent on Human Rights Campaign Foundation’s 16th Annual Scorecard on LGBTQ Workplace Equality

  LabCorp, a leading global life sciences company, announced that it received a perfect score of 100 percent on the 2018 Corporate Equality Index (CEI).

  November 13, 2017

   · 

  3 min read
• BioMidwest

  Canopy Biosciences’s New CRISPR Kits Simplify Gene Editing

  he CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system.

  November 13, 2017

   · 

  1 min read
• Drug Development

  Trovagene Announces Activation of First Clinical Trial Site in Phase Ib/II Acute Myeloid Leukemia Trial for PCM-075

  This trial will enroll subjects in the Phase Ib who have relapsed or have resistant disease to no more than three prior regimens.

  November 13, 2017

   · 

  7 min read
• Drug Development

  Array BioPharma Reports Initial Results From Novel Immunotherapy Combination at the SITC 32nd Annual Meeting

  Array BioPharma today announced data from the Phase Ib clinical trial evaluating the immunotherapy combination of ARRY-382, with Merck’s KEYTRUDA at the SITC 32nd Annual Meeting, being held Nov. 8-12, 2017 in National Harbor, Maryland.

  November 13, 2017

   · 

  6 min read